Peter Casasanto
Corporate Officer/Principal bij SOPHIA GENETICS SA
Profiel
Peter Casasanto is currently the Chief BioPharma Officer at SOPHiA GENETICS SA since 2022.
Previously, he worked as the Vice President-New Commercialization Initiatives at CellCarta Biosciences, Inc. Mr. Casasanto has a graduate degree from Thomas Jefferson University, an undergraduate degree from the University of Maryland, and an MBA from Lebow College of Business.
Actieve functies van Peter Casasanto
Bedrijven | Functie | Begin |
---|---|---|
SOPHIA GENETICS SA | Corporate Officer/Principal | 10-01-2022 |
Eerdere bekende functies van Peter Casasanto
Bedrijven | Functie | Einde |
---|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Opleiding van Peter Casasanto
Lebow College of Business | Masters Business Admin |
Thomas Jefferson University | Graduate Degree |
University of Maryland | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SOPHIA GENETICS SA | Technology Services |
Bedrijven in privébezit | 1 |
---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |